X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA hosts first public workshop on clinical trial diversity

By Stephen J. Ubl  |    June 11, 2021
This week, 500+ health care and community members from over 150 organizations came together at PhRMA’s first stakeholder workshop focused on improving diversity in clinical trials. At the virtual...   Read More

How research evolves and brings new hope to patients

By Stephen J. Ubl  |    June 11, 2021
Before medicines can be made available to patients, they often begin as ideas that are based on newly discovered molecules and cells, strange phenomena or little-understood processes in the body....   Read More

Coming together to fight COVID-19: A conversation with Barry Greene, CEO of Sage Therapeutics

By Stephen J. Ubl  |    June 9, 2021
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. A...   Read More

New reports shed light on key facts about medicines and affordability

By Brian Newell  |    June 8, 2021
A recently released report by IQVIA – an independent organization specializing in health care research – provides new data showing prices for brand medicines went down last year. The report offers...   Read More

Continued R&D into Alzheimer’s disease means hope for patients, families and caregivers

By Richard Moscicki, M.D.  |    June 4, 2021
More than 6 million Americans, most of them age 65 or older, live with Alzheimer’s disease, a devastating degenerative brain disease and the most common form of dementia. After heart disease and...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates